214 related articles for article (PubMed ID: 26172385)
1. Adaptive sample size modification in clinical trials: start small then ask for more?
Jennison C; Turnbull BW
Stat Med; 2015 Dec; 34(29):3793-810. PubMed ID: 26172385
[TBL] [Abstract][Full Text] [Related]
2. Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size.
Mauer M; Collette L; Bogaerts J;
Eur J Cancer; 2012 Jun; 48(9):1386-91. PubMed ID: 22281098
[TBL] [Abstract][Full Text] [Related]
3. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
Chen YH; Li C; Lan KK
Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
[TBL] [Abstract][Full Text] [Related]
4. Optimal promising zone designs.
Hsiao ST; Liu L; Mehta CR
Biom J; 2019 Sep; 61(5):1175-1186. PubMed ID: 30411405
[TBL] [Abstract][Full Text] [Related]
5. Sample size adjustment designs with time-to-event outcomes: A caution.
Freidlin B; Korn EL
Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
[TBL] [Abstract][Full Text] [Related]
6. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
Liu Q; Li G; Anderson KM; Lim P
J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
[TBL] [Abstract][Full Text] [Related]
7. Increasing the sample size when the unblinded interim result is promising.
Chen YH; DeMets DL; Lan KK
Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
[TBL] [Abstract][Full Text] [Related]
8. Optimal adaptive group sequential design with flexible timing of sample size determination.
Cui L; Zhang L; Yang B
Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
[TBL] [Abstract][Full Text] [Related]
9. Adaptive increase in sample size when interim results are promising: a practical guide with examples.
Mehta CR; Pocock SJ
Stat Med; 2011 Dec; 30(28):3267-84. PubMed ID: 22105690
[TBL] [Abstract][Full Text] [Related]
10. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
Lachin JM
Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
[TBL] [Abstract][Full Text] [Related]
11. Precision of maximum likelihood estimation in adaptive designs.
Graf AC; Gutjahr G; Brannath W
Stat Med; 2016 Mar; 35(6):922-41. PubMed ID: 26459506
[TBL] [Abstract][Full Text] [Related]
12. Flexible design of two-stage adaptive procedures for phase III clinical trials.
Koyama T
Contemp Clin Trials; 2007 Jul; 28(4):500-13. PubMed ID: 17307399
[TBL] [Abstract][Full Text] [Related]
13. Flexible two-stage design with sample size reassessment for survival trials.
Desseaux K; Porcher R
Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
[TBL] [Abstract][Full Text] [Related]
14. An adaptive design to bridge the gap between Phase 2b/3 microbicide effectiveness trials and evidence required for licensure.
Taylor DJ; Grobler A; Abdool Karim SS
Clin Trials; 2012 Aug; 9(4):377-84. PubMed ID: 22610168
[TBL] [Abstract][Full Text] [Related]
15. Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.
Shimura M; Maruo K; Gosho M
Pharm Stat; 2018 Sep; 17(5):400-413. PubMed ID: 29687592
[TBL] [Abstract][Full Text] [Related]
16. Sample size re-estimation in group-sequential response-adaptive clinical trials.
Morgan CC
Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
[TBL] [Abstract][Full Text] [Related]
17. Optimal flexible sample size design with robust power.
Zhang L; Cui L; Yang B
Stat Med; 2016 Aug; 35(19):3385-96. PubMed ID: 26999385
[TBL] [Abstract][Full Text] [Related]
18. Sample size re-assessment leading to a raised sample size does not inflate type I error rate under mild conditions.
Broberg P
BMC Med Res Methodol; 2013 Jul; 13():94. PubMed ID: 23870495
[TBL] [Abstract][Full Text] [Related]
19. Comments on 'Adaptive increase in sample size when interim results are promising: a practical guide with examples' by C. R. Mehta and S. J. Pocock.
Glimm E
Stat Med; 2012 Jan; 31(1):98-9; author reply 99-100. PubMed ID: 22213002
[No Abstract] [Full Text] [Related]
20. A variational approach to optimal two-stage designs.
Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
Stat Med; 2019 Sep; 38(21):4159-4171. PubMed ID: 31264243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
